Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 12/20 | 0.35 |
| ▸ | NPY1R | P25929 | 9/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.33 |
| ▸ | NPY2R | P49146 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28406173 | 0.87 | SIRT6 (0.40) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL13949746 | 0.86 | NPY4R (0.43) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL23048407 | 0.86 | NPY4R (0.43) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL8005035 | 0.86 | NPY4R (0.43) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL6366187 | 0.86 | NPY4R (0.34) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL25411854 | 0.86 | NPY4R (0.34) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| Hydrochloric Acid SCHEMBL7302869 | 0.85 | NPY4R (0.43) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| Hydrochloric Acid SCHEMBL28825330 | 0.85 | NPY4R (0.43) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| Hydrochloric Acid SCHEMBL7303864 | 0.85 | NPY4R (0.43) | ALOX15NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL27554606 | 0.84 | CAD (0.39) | ALOX15NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109382756-B | Chemical mechanical polishing method for tungsten | 罗门哈斯电子材料CMP控股股份有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-111760473-A | Composite semipermeable membrane, preparation method and application | 中国石油化工股份有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-111760472-A | Composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-10-13 | — | — | CN | claimed |
| US-10600655-B2 | Chemical mechanical polishing method for tungsten | ROHM AND HAAS ELECTRONIC MATERIALS CMP HOLDINGS, INC. (US) | 2020-03-24 | — | — | US | claimed |
| CN-118373794-B | Isoflavone compound, preparation method thereof and application thereof in pharmacy | 中国中医科学院中药研究所 | 2025-08-29 | — | — | CN | disclosed |
| US-20250271442-A1 | Methods for Detecting Renal Disease | IDEXX LABORATORIES, INC. | 2025-08-28 | — | — | US | disclosed |
| CN-118373794-A | Isoflavone compound, preparation method thereof and application thereof in pharmacy | 中国中医科学院中药研究所 | 2024-07-23 | — | — | CN | disclosed |
| CN-118373794-A | Isoflavone compound, preparation method thereof and application thereof in pharmacy | 中国中医科学院中药研究所 | 2024-07-23 | — | — | CN | disclosed |
| CN-118006673-B | Application of OsOPCL gene in regulating and controlling content of nutrient substances in polished rice | 海南大学三亚南繁研究院 | 2024-07-16 | — | — | CN | disclosed |
| CN-118006673-A | Application of OsOPCL gene in regulating and controlling content of nutrient substances in polished rice | 海南大学三亚南繁研究院 | 2024-05-10 | — | — | CN | disclosed |
| EP-4295907-A2 | METHODS FOR DETECTING RENAL DISEASE | IDEXX LABORATORIES, INC. (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-3274004-B1 | CONTROLLED RELEASE MATRIX BARRIER STRUCTURE FOR SUBCUTANEOUS MEDICAL DEVICES | SURMODICS INC (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20020041899-A1 | Medicament incorporation matrix | Surmodics Coatings, LLC | 2002-04-11 | — | — | US | disclosed |
| WO-2002013871-A2 | MEDICAMENT INCORPORATION MATRIX | SURMODICS, INC. (US) | 2002-02-21 | — | — | WO | disclosed |
| US-5480999-A | CONTAINING AN ACID AND AN ARGININE ANALOGUE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1996-01-02 | — | — | US | disclosed |
| US-5360925-A | Cardio cerebrovascular disorders, antiinflammatory agents and immune disorders | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) | 1994-11-01 | — | — | US | disclosed |
| WO-1994023706-A1 | FOAM CELL DRUG DELIVERY | ENDOCON, INC. (US) | 1994-10-27 | — | — | WO | disclosed |
| EP-0584220-A1 | ENGINEERING THE LOCAL INFLAMMATORY RESPONSE AS A MEANS OF CONTROLLED RELEASE DRUG DELIVERY | ENDOCON, INC. (US) | 1994-03-02 | — | — | EP | disclosed |
| WO-1993023012-A1 | LIQUID-CONTAINING DRUG DELIVERY SYSTEM | ENDOCON, INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| WO-1992020325-A1 | ENGINEERING THE LOCAL INFLAMMATORY RESPONSE AS A MEANS OF CONTROLLED RELEASE DRUG DELIVERY | ENDOCON, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041899-A1 | Medicament incorporation matrix | COL14A1, MATR3, ECPAS | ALOX15 1046/4885NPY4R 3711/4885NPY1R 3473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.